Press Releases

December 5, 2003 Two Citigroup representatives join Lupin’s board

December 5, 2003 Two Citigroup representatives join Lupin’s board

December 5, 2003 Lupin receives IND approval for anti-migraine molecule

October 13, 2003 Lupin promoters, Newbridge call off discussions

October 11, 2003 Lupin Q2 FY 2003-04 net profit before extraordinary items at Rs.518 mn,up 86%; sales up 36% at Rs 3609 mn

October 1, 2003 Lupin receives USFDA approval for ceftriaxone sterile vials for injection

September 25, 2003 Lupin receives USFDA approval for cefotaxime sterile vials for injection

August 25, 2003 Dr. Kamal K. Sharma to join Lupin as Managing Director

July 31, 2003 Lupin Q1 FY 2003-04 net profit up 38% at Rs 280.6 mn; sales up 23% at Rs 2,769 mn